| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 99,
Authors: 417,
Journals: 56,
Outer References: 4520,
Words: 467
Collection span: 2003 - 2005
View: Overview. Sorted by first author.
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 1 | 59 | 8 2003 DEVELOPMENTAL DYNAMICS 228(3):523-534 Amsterdam A Insertional mutagenesis in zebrafish | 0 | 6 |
| 2 | 1 | 105 | 41 2004 GENETICS 168(3):1159-1176 Aye M; Irwin B; Beliakova-Bethell N; Chen E; Garrus J; et al. Host factors that affect Ty3 retrotransposition in Saccharomyces cerevisiae | 0 | 0 |
| 3 | 1 | 50 | 44 2004 HUMAN GENE THERAPY 15(5):445-456 Bao LL; Jaligam V; Zhang XY; Kutner RH; Kantrow SP; et al. Stable transgene expression in tumors and metastases after transduction with lentiviral vectors based on human immunodeficiency virus type 1 | 0 | 1 |
| 4 | 3 | 126 | 35 2004 EXPERT OPINION ON BIOLOGICAL THERAPY 4(9):1423-1434 Barese CN; Goebel WS; Dinauer MC Gene therapy for chronic granulomatous disease | 0 | 0 |
| 5 | 3 | 54 | 38 2004 GENE THERAPY 11:S3-S9 Barquinero J; Eixarch H; Perez-Melgosa M Retroviral vectors: new applications for an old tool | 0 | 0 |
| 6 | 1 | 37 | 5 2003 CURRENT OPINION IN MOLECULAR THERAPEUTICS 5(5):458-462 Baum C; Fehse B Mutagenesis by retroviral transgene insertion: Risk assessment and potential alternatives | 1 | 2 |
| 7 | 2 | 54 | 61 2004 MOLECULAR THERAPY 9(1):5-13 Baum C; von Kalle C; Staal FJT; Li ZX; Fehse B; et al. Chance or necessity? Insertional mutagenesis in gene therapy and its consequences | 5 | 9 |
| 8 | 1 | 3 | 12 2003 QJM-AN INTERNATIONAL JOURNAL OF MEDICINE 96(11):873-874 Berry C Misplaced | 0 | 0 |
| 9 | 1 | 97 | 31 2004 CURRENT GENOMICS 5(1):19-35 Buchschacher GL Safety considerations associated with development and clinical application of lentiviral vector systems for gene transfer | 0 | 0 |
| 10 | 1 | 99 | 1 2003 ARCHIVES OF MEDICAL RESEARCH 34(6):589-599 Bueren JA; Guenechea G; Casado JA; Lamana ML; Segovia JC Genetic modification of hematopoietic stem cells: recent advances in the gene therapy of inherited diseases | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 11 | 1 | 18 | 3 2003 CELL 115(2):135-138 Bushman FD Targeting survival: Integration site selection by retroviruses and LTR-retrotransposons | 13 | 20 |
| 12 | 3 | 64 | 17 2004 AIDS REVIEWS 6(1):13-21 Cereseto A; Giacca M Integration site selection by retroviruses | 0 | 0 |
| 13 | 1 | 67 | 83 2004 WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE 16(1):23-33 Chandler LA; Sosnowski BA Gene therapy for cutaneous wound repair | 0 | 2 |
| 14 | 1 | 42 | 70 2004 NATURE GENETICS 36(3):304-312 Chen WSV; Delrow J; Corrin PD; Frazier JP; Soriano P Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis | 1 | 4 |
| 15 | 3 | 43 | 84 2005 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 329(2):646-652 Chen ZYJ; Kren BT; Wong PYP; Low WC; Steer CJ Sleeping Beauty-mediated down-regulation of huntingtin expression by RNA interference | 0 | 0 |
| 16 | 6 | 59 | 47 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(47):48883-48892 Cherepanov P; Devroe E; Silver PA; Engelman A Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase | 0 | 0 |
| 17 | 3 | 85 | 46 2004 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 113(4):595-603 Chinen J; Puck JM Successes and risks of gene therapy in primary immunodeficiencies | 0 | 5 |
| 18 | 2 | 50 | 45 2004 HUMAN GENE THERAPY 15(8):758-769 Chinnasamy D; Fairbairn LJ; Neuenfeldt J; Treisman JS; Hanson JP; et al. Lentivirus-mediated expression of mutant MGMT(P140K) protects human CD34(+) cells against the combined toxicity of O-6-benzylguanine and 1,3-bis(2-chloroethyl)-nitrosourea or temozolomide | 0 | 0 |
| 19 | 6 | 20 | 98 2005 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 102(5):1275-1276 Engelman A The ups and downs of gene expression and retroviral DNA integration | 0 | 0 |
| 20 | 2 | 10 | 97 2005 PLOS MEDICINE 2(1):22-24 Fischer A; Cavazzana-Calvo M Integration of retroviruses: A fine balance between efficiency and danger | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 21 | 2 | 10 | 59 2004 M S-MEDECINE SCIENCES 20(1):115-117 Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M Gene therapy of children with X-linked severe combined immune deficiency : efficiency and comlications | 0 | 1 |
| 22 | 2 | 88 | 77 2004 SEMINARS IN HEMATOLOGY 41(4):272-278 Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M Gene therapy for immunodeficiency diseases | 0 | 1 |
| 23 | 2 | 33 | 24 2004 BLOOD 104(12):3543-3549 Frank O; Rudolph C; Heberlein C; von Neuhoff N; Schrock E; et al. Tumor cells escape suicide gene therapy by genetic and epigenetic instability | 0 | 0 |
| 24 | 1 | 93 | 9 2003 EXPERT OPINION ON BIOLOGICAL THERAPY 3(8):1241-1251 Fruehauf S; Veldwijk MR; Zeller WJ; Laufs S Prospects and RISC score of viral gene therapy for sarcoma | 0 | 0 |
| 25 | 1 | 32 | 10 2003 GENE THERAPY 10(24):1999-2004 Gaspar HB; Howe S; Thrasher AJ Gene therapy progress and prospects: gene therapy for severe combined immunodeficiency | 1 | 5 |
| 26 | 1 | 38 | 16 2003 SCIENCE 302(5644):415-419 Hacein-Bey-Abina S; Von Kalle C; Schmidt M; McCcormack MP; Wulffraat N; et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 | 43 | 174 |
| 27 | 2 | 39 | 53 2004 JOURNAL OF VIROLOGICAL METHODS 121(2):127-136 Hahm SH; Yi YS; Lee DK; Noh MJ; Yun L; et al. Construction of retroviral vectors with enhanced efficiency of transgene expression | 0 | 0 |
| 28 | 1 | 71 | 55 2004 JOURNAL OF VIROLOGY 78(12):6122-6133 Han YF; Lassen K; Monie D; Sedaghat AR; Shimoji S; et al. Resting CD4(+) T cells from human immunodeficiency virus type I (HIV-1)-infected individuals carry integrated HIV-1 Genomes within actively transcribed host genes | 2 | 4 |
| 29 | 3 | 38 | 22 2004 BLOOD 104(8):2281-2290 Hanawa H; Hargrove PW; Kepes S; Srivastava DK; Nienhuis AW; et al. Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine beta-thalassemia | 0 | 0 |
| 30 | 3 | 80 | 21 2004 BLOOD 103(11):4062-4069 Hanawa H; Hematti P; Keyvanfar K; Metzger ME; Krouse A; et al. Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system | 4 | 6 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 31 | 2 | 128 | 30 2004 CURRENT GENE THERAPY 4(3):263-276 Haviernik P; Bunting KD Safety concerns related to hematopoietic stem cell gene transfer using retroviral vectors | 0 | 0 |
| 32 | 3 | 53 | 74 2004 PLOS BIOLOGY 2(12):2183-2190 Hematti P; Hong BK; Ferguson C; Adler R; Hanawa H; et al. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells | 0 | 0 |
| 33 | 2 | 87 | 89 2005 CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT 8(2):199-206 Herzog RW Recent advances in hepatic gene transfer: More efficacy and less immunogenicity | 0 | 0 |
| 34 | 2 | 58 | 60 2004 MOLECULAR CELL 13(3):403-414 Hickman AB; Ronning DR; Perez ZN; Kotin RM; Dyda F The nuclease domain of adeno-associated virus rep coordinates replication initiation using two distinct DNA recognition interfaces | 0 | 4 |
| 35 | 3 | 24 | 20 2004 BIOLOGY OF REPRODUCTION 71(2):405-409 Hofmann A; Zakhartchenko V; Weppert M; Sebald H; Wenigerkind H; et al. Generation of transgenic cattle by lentiviral gene transfer into oocytes | 1 | 3 |
| 36 | 5 | 195 | 67 2004 MOLECULAR THERAPY 10(3):417-431 Horn PA; Morris JC; Neff T; Kiem HP Stem cell gene transfer-efficacy and safety in large animal studies | 0 | 0 |
| 37 | 2 | 45 | 36 2004 FOLIA BIOLOGICA 50(3-4):107-119 Hughes SH The RCAS vector system | 0 | 0 |
| 38 | 2 | 73 | 51 2004 JOURNAL OF CLINICAL INVESTIGATION 114(7):953-962 Imren S; Fabry ME; Westerman KA; Pawliuk R; Tang P; et al. High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells | 1 | 1 |
| 39 | 2 | 4 | 25 2004 CANADIAN MEDICAL ASSOCIATION JOURNAL 170(12):1785-1786 Johnston J; Baylis F Gene therapy: two steps forward, one step back | 0 | 0 |
| 40 | 2 | 42 | 63 2004 MOLECULAR THERAPY 9(4):548-556 Kankkonen HM; Vahakangas E; Marr RA; Pakkanen T; Laurema A; et al. Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 41 | 1 | 36 | 33 2004 DEVELOPMENTAL CELL 7(1):133-144 Kawakami K; Takeda H; Kawakami N; Kobayashi M; Matsuda N; et al. A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish | 0 | 5 |
| 42 | 2 | 84 | 76 2004 SCIENCE 303(5664):1626-1632 Kazazian HH Mobile elements: Drivers of genome evolution | 0 | 36 |
| 43 | 2 | 35 | 62 2004 MOLECULAR THERAPY 9(3):389-395 Kiem HP; Sellers S; Thomasson B; Morris JC; Tisdale JF; et al. Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: No progression to clonal hematopoiesis or leukemia | 4 | 8 |
| 44 | 1 | 331 | 29 2004 CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION 14(1-2):89-136 Klamut HJ; Chen ST; Lau KHW; Baylink DJ Progress toward skeletal gene therapy | 0 | 0 |
| 45 | 1 | 294 | 88 2005 CURRENT GENOMICS 6(1):13-37 Kremer EJ Gene transfer to the central nervous system: Current state of the art of the viral vectors | 0 | 0 |
| 46 | 2 | 79 | 82 2004 TRENDS IN MOLECULAR MEDICINE 10(11):525-531 Lassen K; Han YF; Zhou Y; Siliciano J; Siliciano RF The multifactorial nature of HIV-1 latency | 1 | 1 |
| 47 | 2 | 45 | 69 2004 MOLECULAR THERAPY 10(5):874-881 Laufs S; Nagy KZ; Giordano FA; Hotz-Wagenblatt A; Zeller WJ; et al. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns | 0 | 0 |
| 48 | 6 | 108 | 18 2004 AIDS REVIEWS 6(4):199-207 Lehmann-Che J; Saib A Early stages of HIV replication: How to hijack cellular functions for a successful infection | 0 | 0 |
| 49 | 2 | 145 | 49 2004 JOURNAL OF BIOMEDICAL SCIENCE 11(4):439-449 Lever AML; Strappe PM; Zhao J Lentiviral vectors | 0 | 0 |
| 50 | 6 | 49 | 19 2004 BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY 17(3):493-503 Li ZX; Modlich U; Baum C Safety and efficacy in retrovirally modified haematopoietic cell therapy | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 51 | 3 | 48 | 48 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(53):55570-55577 Llano M; Delgado S; Vanegas M; Poeschla EM Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase | 0 | 0 |
| 52 | 1 | 79 | 57 2004 JOURNAL OF VIROLOGY 78(17):9524-9537 Llano M; Vanegas M; Fregoso O; Saenz D; Chung S; et al. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes | 4 | 4 |
| 53 | 3 | 19 | 99 2005 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 102(5):1436-1441 Maxfield LF; Fraize CD; Coffin JM Relationship between retroviral DNA-integration-site selection and host cell transcription | 1 | 1 |
| 54 | 2 | 90 | 71 2004 NEW ENGLAND JOURNAL OF MEDICINE 350(9):913-922 McCormack MP; Rabbitts TH Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency | 4 | 20 |
| 55 | 2 | 39 | 73 2004 PLOS BIOLOGY 2(8):1127-1137 Mitchell RS; Beitzel BF; Schroder ARW; Shinn P; Chen HM; et al. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences | 0 | 0 |
| 56 | 1 | 83 | 32 2004 CURRENT HIV RESEARCH 2(2):185-191 Morris KV; Rossi JJ Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection | 0 | 2 |
| 57 | 2 | 32 | 92 2005 JOURNAL OF VIROLOGY 79(6):3606-3614 Nakai H; Wu XL; Fuess S; Storm TA; Munroe D; et al. Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver | 0 | 0 |
| 58 | 4 | 43 | 58 2004 JOURNAL OF VIROLOGY 78(21):11656-11663 Narezkina A; Taganov KD; Litwin S; Stoyanova R; Hayashi J; et al. Genome-wide analyses of avian sarcoma virus integration sites | 3 | 3 |
| 59 | 4 | 41 | 86 2005 BLOOD 105(3):997-1002 Neff T; Beard BC; Peterson LJ; Anandakumar P; Thompson J; et al. Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy | 0 | 0 |
| 60 | 2 | 77 | 91 2005 JOURNAL OF VIROLOGY 79(1):67-78 Nielsen AA; Sorensen AB; Schmidt J; Pedersen FS Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 61 | 1 | 46 | 66 2004 MOLECULAR THERAPY 10(2):260-268 Ohlfest JR; Lobitz PD; Perkinson SG; Largaespada DA Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system | 2 | 2 |
| 62 | 2 | 165 | 52 2004 JOURNAL OF GENE MEDICINE 6:S67-S82 Pages JC; Bru T Toolbox for retrovectorologists | 0 | 2 |
| 63 | 1 | 44 | 34 2004 EXPERT OPINION ON BIOLOGICAL THERAPY 4(7):1103-1113 Pardridge WM Intravenous, non-viral RNAi gene therapy of brain cancer | 0 | 1 |
| 64 | 1 | 96 | 6 2003 CURRENT OPINION IN MOLECULAR THERAPEUTICS 5(5):508-516 Persons DA Update on gene therapy for hemoglobin disorders | 2 | 3 |
| 65 | 2 | 56 | 42 2004 GENOME BIOLOGY 5(10) Peterson-Burch BD; Nettleton D; Voytas DF Genomic neighborhoods for Arabidopsis retrotransposons: a role for targeted integration in the distribution of the Metaviridae | 0 | 0 |
| 66 | 4 | 58 | 81 2004 TRANSGENIC RESEARCH 13(6):513-522 Pfeifer A Lentiviral transgenesis | 0 | 0 |
| 67 | 1 | 144 | 7 2003 CURRENT OPINION IN MOLECULAR THERAPEUTICS 5(5):529-540 Poeschla EM Non-primate lentiviral vectors | 1 | 4 |
| 68 | 3 | 98 | 94 2005 NATURE REVIEWS DRUG DISCOVERY 4(3):236-248 Pommier Y; Johnson AA; Marchand C Integrase inhibitors to treat HIV/AIDS | 0 | 0 |
| 69 | 1 | 52 | 4 2003 CURRENT OPINION IN MOLECULAR THERAPEUTICS 5(4):376-382 Portlock JL; Calos MP Site-specific genomic strategies for gene therapy | 0 | 1 |
| 70 | 3 | 41 | 23 2004 BLOOD 104(12):3445-3453 Puthenveetil G; Scholes J; Carbonell D; Oureshi N; Xia P; et al. Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 71 | 2 | 34 | 68 2004 MOLECULAR THERAPY 10(4):660-670 Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors | 0 | 0 |
| 72 | 1 | 53 | 56 2004 JOURNAL OF VIROLOGY 78(12):6190-6199 Serhan F; Penaud M; Petit C; Leste-Lasserre T; Trajcevski S; et al. Early detection of a two-long-terminal-repeat junction molecule in the cytoplasm of recombinant murine leukemia virus-infected cells | 0 | 1 |
| 73 | 1 | 32 | 85 2005 BIOESSAYS 27(2):122-125 Shapiro JA Retrotransposons and regulatory suites | 0 | 0 |
| 74 | 1 | 93 | 90 2005 GENE 345(1):91-100 Shapiro JA A 21st century view of evolution: genome system architecture, repetitive DNA, and natural genetic engineering | 0 | 0 |
| 75 | 2 | 31 | 95 2005 NUCLEIC ACIDS RESEARCH 33(2) Shigeoka T; Kawaichi M; Ishida Y Suppression of nonsense-mediated mRNA decay permits unbiased gene trapping in mouse embryonic stem cells | 0 | 0 |
| 76 | 1 | 81 | 72 2004 ONCOGENE 23(24):4297-4307 Shigesada K; van de Sluis B; Liu PP Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11 | 0 | 1 |
| 77 | 1 | 46 | 26 2004 CANCER RESEARCH 64(13):4419-4427 Shin MS; Fredrickson TN; Hartley JW; Suzuki T; Agaki K; et al. High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas | 0 | 1 |
| 78 | 1 | 51 | 75 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(24):9039-9044 Smith S; Hwang JY; Banerjee S; Majeed A; Gupta A; et al. Mutator genes for suppression of gross chromosomal rearrangements identified by a genome-wide screening in Saccharomyces cerevisiae | 0 | 3 |
| 79 | 1 | 43 | 54 2004 JOURNAL OF VIROLOGY 78(11):5848-5855 Taganov KD; Cuesta I; Daniel R; Cirillo LA; Katz RA; et al. Integrase-specific enhancement and suppression of retroviral DNA integration by compacted chromatin structure in vitro | 1 | 3 |
| 80 | 1 | 15 | 13 2003 SCIENCE 300(5626):1670-1671 Trono D Picking the right spot | 2 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 81 | 1 | 22 | 27 2004 CELLULAR AND MOLECULAR LIFE SCIENCES 61(6):721-726 Tsyba L; Rynditch AV; Boeri E; Jabbari K; Bernardi G Distribution of HIV-1 in the genomes of AIDS patients | 0 | 0 |
| 82 | 3 | 216 | 37 2004 FRONTIERS IN BIOSCIENCE 9:3187-3208 Turlure F; Devroe E; Silver PA; Engelman A Human cell proteins and human immunodeficiency virus DNA integration | 3 | 4 |
| 83 | 2 | 95 | 79 2004 SEMINARS IN THROMBOSIS AND HEMOSTASIS 30(2):185-195 Van Damme A; Chuah MKL; Collen D; VandenDriessche T Onco-Retroviral and lentiviral vector-based gene therapy for hemophilia: Preclinical studies | 0 | 2 |
| 84 | 1 | 74 | 80 2004 STEM CELLS 22(3):324-333 Vanderbyl S; MacDonald GN; Sidhu S; Gung L; Telenius A; et al. Transfer and stable transgene expression of a mammalian artificial chromosome into bone marrow-derived human mesenchymal stem cells | 0 | 2 |
| 85 | 1 | 55 | 43 2004 HUMAN GENE THERAPY 15(4):361-372 Vargas J; Gusella GL; Najfeld V; Klotman ME; Cara A Novel integrase-defective lentiviral episomal vectors for gene transfer | 0 | 1 |
| 86 | 1 | 86 | 11 2003 JOURNAL OF VIROLOGY 77(23):12507-12522 Violot S; Hong SS; Rakotobe D; Petit C; Gay B; et al. The human Polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1 | 5 | 6 |
| 87 | 5 | 22 | 50 2004 JOURNAL OF CLINICAL INVESTIGATION 114(7):889-891 von Kalle C; Baum C; Williams DA Lenti in red: progress in gene therapy for human hemoglobinopathies | 0 | 0 |
| 88 | 5 | 138 | 78 2004 SEMINARS IN HEMATOLOGY 41(4):303-318 von Kalle C; Fehse B; Layh-Schmitt G; Schmidt M; Kelly P; et al. Stem cell clonality and genotoxicity in hematopoietic cells: Gene activation side effects should be avoidable | 0 | 0 |
| 89 | 1 | 68 | 39 2004 GENE THERAPY 11:S92-S97 Waddington SN; Kennea NL; Buckley SMK; Gregory LG; Themis M; et al. Fetal and neonatal gene therapy: benefits and pitfalls | 0 | 1 |
| 90 | 1 | 28 | 40 2004 GENE THERAPY 11(8):711-721 Wang Z; Troilo PJ; Wang X; Griffiths TG; Pacchione SJ; et al. Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation | 0 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 91 | 2 | 9 | 15 2003 SCIENCE 302(5644):400-401 Williams DA; Baum C Gene therapy - New challenges ahead | 3 | 16 |
| 92 | 4 | 69 | 96 2005 PEDIATRIC NEPHROLOGY 20(2):118-124 Worgall S A realistic chance for gene therapy in the near future | 0 | 0 |
| 93 | 3 | 66 | 28 2004 CELLULAR AND MOLECULAR LIFE SCIENCES 61(19-20):2588-2596 Wu X; Burgess SM Integration target site selection for retroviruses and transposable elements | 0 | 0 |
| 94 | 0 | 18 | 14 2003 SCIENCE 300(5626):1749-1751 Wu XL; Li Y; Crise B; Burgess SM Transcription start regions in the human genome are favored targets for MLV integration | 98 | 98 |
| 95 | 5 | 63 | 93 2005 MOLECULAR AND CELLULAR BIOLOGY 25(6):2085-2094 Yant SR; Wu XL; Huang Y; Garrison B; Burgess SM; et al. High-resolution genome-wide mapping of transposon integration in mammals | 0 | 0 |
| 96 | 1 | 19 | 2 2003 BIOTECHNIQUES 35(5):1072-+ Yao AQ; Chiu R; Vora A; Brown DB; Grandgenett D; et al. Avian retrovirus integrase-enhanced transgene integration into mammalian cell DNA in vivo | 0 | 1 |
| 97 | 2 | 38 | 65 2004 MOLECULAR THERAPY 10(1):27-36 Yao SY; Sukonnik T; Kean T; Bharadwaj RR; Pasceri P; et al. Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications | 0 | 0 |
| 98 | 1 | 114 | 87 2005 CURRENT GENE THERAPY 5(1):25-35 Yi Y; Hahm SH; Lee KH Retroviral gene therapy: Safety issues and possible solutions | 0 | 0 |
| 99 | 1 | 27 | 64 2004 MOLECULAR THERAPY 9(6):923-931 Zielske SP; Lingas KT; Li Y; Gerson SL Limited lentiviral transgene expression with increasing copy number in an MGMT selection model: Lack of copy number selection by drug treatment | 0 | 0 |
Generated by: HistCite 2004.12.21